1004791-13-2

Upstream product

• 79069-63-9 tert-butyl [(2R,3R)-3-(benzyloxy)-1-hydroxybutan-2-yl]carbamate 
• 1004791-10-9 ((2R,3R)-3-benzyloxy-2-t-butoxycarbonylaminobutoxy)acetic acid t-butyl ester 
• 1004791-11-0 (R)-3-((R)-1-benzyloxyethyl)-5-oxomorpholine-4-carboxylic acid t-butyl ester 
• 1004791-09-6 (R)-5-((R)-1-benzyloxyethyl)morpholine-3-one 
• 1004791-12-1 ((2R,3R)-3-benzyloxy-2-t-butoxycarbonyl-aminobutoxy)acetic acid 
• 6638-79-5 N,O-dimethylhydroxylamine*hydrochloride 

Downstream Products

• 1004791-22-3 {(1R,2R)-2-benzyloxy-1-[2-(4-chlorophenyl)-2-oxoethoxymethyl]propyl}carbamic acid t-butyl ester 
• 1004791-26-7 (S)-1-[(3R,5R)-5-(4-chlorophenyl)-morpholine-3-yl]ethanol 
• 1004791-24-5 (R)-1-[(3R,5R)-5-(4-chlorophenyl)-morpholine-3-yl]ethanol 
• 1004791-23-4 (3R,5R)-3-((R)-1-benzyloxyethyl)-5-(4-chlorophenyl)morpholine 
• 1004791-25-6 4-nitrobenzoic acid (S)-1-[(3R,5R)-5-(4-chlorophenyl)morpholine-3-yl]ethyl ester 
• 1004791-27-8 (1S,6R,9aR)-6-(4-chlorophenyl)-1-methyltetrahydro-[1,4]oxazino[3,4-c][1,4]oxazine-3,4-dione 

Relevant academic research and scientific papers

TWO CYCLIC OXOMORPHORIN DERIVATIVES

The present invention relates to a compound represented by formula (I): wherein R1 represents a C1-3 alkyl group, R2 represents a hydrogen atom or a C1-3 alkyl group, Ar represents a phenyl group or the like which may be substituted with 1 to 3 substituents, X represents an oxygen atom or the like, n and m are the same or different and integers of 0 to 2, or a pharmacologically acceptable salt, and use thereof as a medicament.